Scandinavian Medical Solutions A/S
CSE:SMSMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Scandinavian Medical Solutions A/S
CSE:SMSMED
|
DK |
|
SiteOne Landscape Supply Inc
NYSE:SITE
|
US |
|
Surya Semesta Internusa Tbk PT
IDX:SSIA
|
ID |
|
Quanta Services Inc
NYSE:PWR
|
US |
|
RWS Holdings PLC
LSE:RWS
|
UK |
|
Tesmec SpA
MIL:TES
|
IT |
|
B
|
Bank Handlowy w Warszawie SA
WSE:BHW
|
PL |
|
P
|
Peakstone Realty Trust
NYSE:PKST
|
US |
|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
US |
|
Nestle SA
SIX:NESN
|
CH |
Wall St Price Targets
SMSMED Price Targets Summary
Scandinavian Medical Solutions A/S
According to Wall Street analysts, the average 1-year price target for SMSMED is 3.06 DKK with a low forecast of 3.03 DKK and a high forecast of 3.15 DKK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SMSMED's stock price target?
Price Target
3.06
DKK
According to Wall Street analysts, the average 1-year price target for SMSMED is 3.06 DKK with a low forecast of 3.03 DKK and a high forecast of 3.15 DKK.
What is the Revenue forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
9%
Over the last 4 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
132%
Over the last 4 years, the compound annual growth rate for Operating Income has been -36%. The projected CAGR for the next 3 years is 132%.
What is the Net Income forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
746%
Over the last 4 years, the compound annual growth rate for Net Income has been -76%. The projected CAGR for the next 3 years is 746%.